Clinical significance of serum lactate dehydrogenase andβ2-microglobulinin in patients with diffuse large B-cell lymphoma

Shuqing ZHAO,Junmin LI,Li CHEN,Chenmin YANG
2015-01-01
Chinese Clinical Oncology
Abstract:Objective To investigate the clinical significance of serum levels of lactate dehydrogenase( LDH) andβ2?micro?globulin(β2?MG) in diffuse large B?cell lymphoma(DLBCL). Methods The serum levels of LDH and β2?MG of 58 patients with DLBCL were measured by rate method and radioimmunoassay. Besides, the clinicopathological characteristics of the patients such as gender, age, B symptoms, clinical stages, ECOG score of performance status( ECOG?PS) and bone marrow invasion were summarized and anylyzed. Meanwhile, the association between the level change of LDH and β2?MG after chemotherapy and therapeutic effectiveness was also evaluated. Results The levels of LDH andβ2?MG in the advanced stage group,ECOG≥2 group, bone marrow invasion group were significantly higher than those of their counterpart (P<0?05).The level of β2?MG in aged over 60 patients was higher than that of younger ones ( P<0?05) ,but there was no statistical significance in the LDH level( P>0?05) . The level of LDH in B symptoms group was higher than that of without B symptoms( P<0?05) ,but there was no statistical significance in the β2?MG level ( P>0?05) . There was no statistical significance about LDH andβ2?MG levels in gender( P>0?05) . The levels of LDH andβ2?MG in positive response group significantly decreased after chemotherapy ( P<0?05) . Conclusion LDH andβ2?MG can be taken as indica?tors in classifying the clinical phase and judging whether there is bone marrow infiltration or not, and evaluating the chemotherapeutic effectiveness of DLBCL patients.
What problem does this paper attempt to address?